About the Phase 1 Trial
Trial Name: A Phase 1 Multi-center Clinical Trial Evaluating the Safety and Tolerability of 5-aminolevulinic Acid Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy in Patients With Recurrent High Grade Glioma
ClinicalTrials.gov Identifier: NCT05362409
Sponsor: Alpheus Medical, Inc.
Recruitment Contact: Alpheus Medical, (612) 234-4009, firstname.lastname@example.org
Completion Date: April 2024